Berg Katherine M, Grossestreuer Anne V, Andersen Lars W, Liu Xiaowen, Donnino Michael W
Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Center for Resuscitation Science, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Crit Care Explor. 2021 Nov 17;3(11):e0579. doi: 10.1097/CCE.0000000000000579. eCollection 2021 Nov.
Lower oxygen consumption is associated with worse survival in septic shock and in other forms of critical illness. No treatment that increases oxygen extraction, a key determinant of oxygen consumption, has been found. Thiamine is required for aerobic metabolism, and deficiency is common in the critically ill.
We evaluated the effect of thiamine on oxygen consumption in patients requiring mechanical ventilation for an acute illness.
Phase II, randomized, double-blind, and placebo-controlled trial.
ICUs in a tertiary care hospital in the United States. Patients admitted to the ICU and requiring mechanical ventilation were screened for enrollment.
After enrollment, baseline measurement of oxygen consumption and baseline laboratories including lactate, central venous oxygen saturation, and pyruvate dehydrogenase, a single dose of 200 mg IV thiamine or placebo was administered. Oxygen consumption was then monitored for 6 additional hours and repeat laboratories were drawn at the end of the protocol.
The primary outcome was the change in oxygen consumption. Analysis was done using linear regression with a first-order autoregressive variance-covariance structure to account for repeated measures within subjects. Secondary outcomes included change in lactate, central venous oxygen saturation, and pyruvate dehydrogenase quantity and activity.
Sixty-seven patients were enrolled. After excluding 11 patients due to inadequate quantity or quality of oxygen consumption data, 56 patients were included. There was no difference in change in oxygen consumption in the 6 hours after study drug. Results for secondary outcomes were similarly negative. In the prespecified subgroup of 18 thiamine deficient patients, there was a difference in the two oxygen consumption curves ( = 0.006), although no difference in median oxygen consumption or area under the curve.
A single dose of IV thiamine did not alter oxygen consumption in patients requiring mechanical ventilation for acute illness.
在感染性休克及其他形式的危重症中,较低的氧耗与较差的生存率相关。尚未发现能增加氧摄取(氧耗的关键决定因素)的治疗方法。硫胺素是有氧代谢所必需的,且在危重症患者中普遍缺乏。
我们评估了硫胺素对因急性疾病需要机械通气的患者氧耗的影响。
II期随机双盲安慰剂对照试验。
美国一家三级医疗中心的重症监护病房。筛选入住重症监护病房且需要机械通气的患者以纳入研究。
入选后,测量氧耗基线及包括乳酸、中心静脉血氧饱和度和丙酮酸脱氢酶在内的基线实验室指标,静脉注射单剂量200mg硫胺素或安慰剂。然后监测氧耗6小时,并在方案结束时抽取重复的实验室指标。
主要结局是氧耗的变化。采用具有一阶自回归方差协方差结构的线性回归进行分析,以考虑受试者内的重复测量。次要结局包括乳酸、中心静脉血氧饱和度以及丙酮酸脱氢酶数量和活性的变化。
67名患者入选。因氧耗数据量或质量不足排除11名患者后,纳入56名患者。研究药物使用后6小时内氧耗变化无差异。次要结局结果同样为阴性。在预先设定的18名硫胺素缺乏患者亚组中,两条氧耗曲线存在差异(P = 0.006),尽管中位氧耗或曲线下面积无差异。
单剂量静脉注射硫胺素未改变因急性疾病需要机械通气患者的氧耗。